Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-09-14 20:57:19 ET · period of report 2026-09-11 · accession 0001819879-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-14 20:57 | 2026-09-11 | ANIP | Thoma Jeanne | Dir | S - Sale | $71.53 | -1,000 | 26.8K | -4% | -$71.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | S | D | 1,000 | $71.53 | 26,762 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2026. |